Aromatic L-amino Acid Decarboxylase (AADC) Deficiency

DBCOND0053491Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutritional and Metabolic Diseases

Aromatic L-amino Acid Decarboxylase (AADC) Deficiency is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Aromatic L-amino Acid Decarboxylase Deficiency · Aromatic Amino Acid Decarboxylase Deficiency · AADC Deficiency
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0531898ICD-10E70.81SNOMED CT124600004MedDRA10084110UMLSC0342686

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Aromatic L-amino Acid Decarboxylase (AADC) Deficiency share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In